Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
≥96% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Protected from light,Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Subclass | Benzoic acids and derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Benzoic acids and derivatives |
| Alternative Parents | m-Xylenes Benzoyl derivatives Hydroxamic acids Organonitrogen compounds Organic oxides Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aromatic homomonocyclic compounds |
| Substituents | Benzoic acid or derivatives - M-xylene - Xylene - Benzoyl - Hydroxamic acid - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Carbonyl group - Aromatic homomonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as benzoic acids and derivatives. These are organic compounds containing a carboxylic acid substituent attached to a benzene ring. |
| External Descriptors | Not available |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 |
| Solubility | Soluble in DMSO |
|---|---|
| Molecular Weight | 294.350 g/mol |
| XLogP3 | 1.800 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 294.158 Da |
| Monoisotopic Mass | 294.158 Da |
| Topological Polar Surface Area | 87.700 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 326.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
No tested applications, protocols, or recommended dilutions are provided in the Product Data for this item.
General guidance for preparing working solutions (not item-specific):
For cell-based work, confirm media compatibility, serum binding, and cytotoxicity in pilot runs and adhere to institutional biosafety protocols. Refer to your assay kit or method SOPs for detailed steps.
General/literature context (no medical/clinical claims; not item-specific):
For specific potency values (IC50/Ki), isoform selectivity, and cell-permeability parameters, consult primary literature and verify against your experimental platform; these are assay-condition dependent.
This product is a bioactive small molecule rather than a buffering agent. Classical buffer systems (e.g., phosphate, HEPES, Tris) are used to formulate assay media in which LMK 235 is tested.
General guidance for preparing assay buffers (not item-specific):
Because LMK 235 is not itself a buffer component, refer instead to the Reaction & Applications and Biological Roles sections for practical assay use considerations.
As LMK 235 is a specific bioactive small molecule (not a process solvent or reagent), “green alternative” discussions typically relate to handling media and formulation vehicles rather than replacing the compound itself.
Greener handling choices (general):
Comparison (general; not item-specific):
Note: There is no direct “green substitute” for LMK 235’s biochemical activity; changes to the probe alter target engagement. Focus sustainability efforts on solvent choice, scale, and waste management.
No pharmacopoeial status or excipient role is provided for this item.
Context (general; no therapeutic claims):
If you require material for regulated development (GLP/GMP) or with specific impurity limits, stability studies, or formal specifications, contact technical support to discuss feasibility. Otherwise, use this material strictly for non-clinical laboratory research.
Item-specific specs (this catalog entry):
General/literature context for LMK 235-type HDAC inhibitors (for planning only; not item specifications):
Practical notes (general):
Interpretation and guidance:
This product is primarily a bioactive screening compound rather than a synthetic reagent. No manufacturer reaction applications are provided for this SKU.
Research applications (general/literature context for LMK 235):
Practical tips (general):
For synthetic reactions or named-reaction roles: not typically applicable; LMK 235 is not employed as a reagent or catalyst in preparative organic synthesis.
Not typically applicable: LMK 235 is a finished bioactive probe, not a reagent or catalyst for synthetic transformations.
Assay conditions (general/literature guidance only; not item-specific):
Expected potencies, selectivity ratios, and precise incubation parameters are assay- and isoform-dependent and should be optimized empirically. Always confirm with primary literature and pilot experiments.
Product Data safety fields:
General safety guidance for small-molecule HDAC inhibitors (literature/practice; not a substitute for SDS):
Item-specific solubility is not provided. The following is general guidance for small-molecule HDAC inhibitors like LMK 235 (literature/practice):
Small comparison (general):
Always confirm item-specific solubility and stability with small-scale tests and refer to the CoA.
From Product Data (item-specific):
General best practices (not item-specific):
Always consult the item’s CoA/SDS for any additional storage or stability notes specific to the supplied lot. Research use only.
Structural features (general/literature context):
Identity notes:
LMK 235 is a target-specific bioactive compound and is not typically used as a synthetic building block or reagent. Nevertheless, understanding its functional groups can aid in impurity analysis, derivatization for SAR, or analytical standard preparation.
General functional group considerations (literature context):
Potential laboratory uses (non-preparative):
For retrosynthesis or as a coupling partner in named reactions: not commonly applicable. If modifications are desired (e.g., SAR exploration), standard amide-coupling, hydroxamate formation, and carbamate-protection strategies are typically employed on the parent scaffold in medicinal chemistry programs.
Item-specific target data are not provided in the Product Data for this SKU.
General/literature context (for planning only):
Because no manufacturer-verified specificity data are supplied here, treat any literature claims as provisional and verify with your in-house assays.